Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record history now includes a new revision entry v3.6.2, and the previous revision v3.6.0 has been removed.
    Difference
    0.1%
    Check dated 2026-06-26T19:28:43.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.0 was added to the record history, representing an updated version of the study record. The previous revision v3.5.5 is now superseded in the history.
    Difference
    0.3%
    Check dated 2026-06-12T14:07:28.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A new revision tag v3.5.5 was added to the page's history. The previous revision tag v3.5.4 was removed from the current listing.
    Difference
    0.1%
    Check dated 2026-06-05T11:27:52.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 is added, replacing the previous v3.5.3. This indicates a small update to the page's versioning history.
    Difference
    0.1%
    Check dated 2026-05-15T02:11:40.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, was added to the history, and the previous revision v3.5.2 was removed.
    Difference
    0.1%
    Check dated 2026-04-30T16:34:10.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The history now shows a new revision v3.5.2 added and the previous v3.5.0 revision removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:12:58.000Z thumbnail image

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.